Recently, the methylation level of HOXA1 was used to accurately differentiate between cholangiocarcinoma and benign biliary stricture from brushed biliary samples in clinical trial NCT04568512 [58]. This evidence concerns the gene HOXA1 and cholangiocarcinoma.